Doctors study when to pull back powerful Fungus-Fighting drugs
NCT ID NCT03774316
Summary
This study observed how often doctors reduced or stopped antifungal medications in critically ill patients with weakened immune systems who were suspected of having a serious yeast infection. Researchers tracked 275 patients across 14 intensive care units to see if this 'de-escalation' was safe and what factors made it more likely. The goal was to gather information to help doctors use these strong drugs more carefully, balancing treatment needs against side effects and cost.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Lille
Lille, 59000, France
Conditions
Explore the condition pages connected to this study.